Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2021

May 17, 2021

SELL
$14.0 - $20.72 $358,400 - $530,432
-25,600 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$12.67 - $26.23 $324,352 - $671,488
25,600 New
25,600 $503,000
Q1 2020

May 15, 2020

SELL
$5.69 - $17.78 $28,450 - $88,900
-5,000 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$10.89 - $16.79 $62,073 - $95,703
-5,700 Reduced 53.27%
5,000 $82,000
Q3 2019

Nov 14, 2019

BUY
$12.03 - $19.94 $24,060 - $39,880
2,000 Added 22.99%
10,700 $151,000
Q2 2019

Aug 14, 2019

BUY
$19.05 - $41.04 $165,735 - $357,048
8,700 New
8,700 $175,000

Others Institutions Holding ATRA

About Atara Biotherapeutics, Inc.


  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $1.13B
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.